Ibuprofen Accord Healthcare

Ibuprofen, the active ingredient in Ibuprofen Accord Healthcare, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a oral tablet for oral use. It treats mild to moderate pain, fever and inflammation in adults and children as appropriate.

GNH USA supplies Ibuprofen Accord Healthcare as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts on inflammatory pathways to relieve pain and reduce fever.

- Mild to moderate pain: provides analgesic relief for headaches, dental pain, musculoskeletal discomfort. - Fever: lowers elevated body temperature associated with infections or inflammatory conditions. - Inflammatory arthritis (osteoarthritis, rheumatoid arthritis): reduces joint inflammation and improves mobility.

Adverse reactions may occur with ibuprofen use and vary in frequency.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia - Nausea or vomiting - Headache - Dizziness - Mild skin rash - Elevated blood pressure

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation - Acute renal failure or worsening of chronic kidney disease - Severe hypersensitivity reactions including anaphylaxis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Cardiovascular thrombotic events such as myocardial infarction or stroke - Hepatotoxicity in susceptible individuals

Before using ibuprofen, consider the following safety measures.

- Assess renal function: avoid or adjust dose in severe renal impairment. - Monitor gastrointestinal risk: use with food or a gastro‑protective agent in high‑risk patients. - Avoid in known hypersensitivity to NSAIDs or aspirin. - Use cautiously in cardiovascular disease: may increase thrombotic risk. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture.

Ibuprofen can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, DOACs): increased risk of bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding risk. - ACE inhibitors or diuretics: may impair renal function, especially in volume‑depleted patients.

Moderate Interactions (Monitor Closely): - Other NSAIDs: additive gastrointestinal toxicity. - Corticosteroids: increased risk of ulceration and bleeding.